GlaxoSmithKline

9. GlaxoSmithKline

Total Ad Spend: $170.6 million
Television: $70.3 million
Magazine: $84.8 million
Other: $15.5 million

GlaxoSmithKline ($GSK) is counting on respiratory drugs to help get it through rough times and spent nearly 60% of its total advertising budget on the inhaler product Advair Diskus alone. It also backed up its fish-oil cholesterol pill Lovaza as a rival from Amarin hit the market.

In the spotlight

Advair Diskus, $99 million
Lovaza, $22.8 million
Jalyn, $14 million


 

GlaxoSmithKline
Read more on

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.